Atlas Trials

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

Clinical trial NCT01246908 · COMPLETED

Trial details

NCT number
NCT01246908
Sponsor
CeNeRx BioPharma Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Treatment Resistant Depression
Start date
2010-11-01
Primary completion
2012-05-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.